| Literature DB >> 25297387 |
Jeffrey B Russ1, Julia A Kaltschmidt2.
Abstract
Every behaviour of an organism relies on an intricate and vastly diverse network of neurons whose identity and connectivity must be specified with extreme precision during development. Intrinsically, specification of neuronal identity depends heavily on the expression of powerful transcription factors that direct numerous features of neuronal identity, including especially properties of neuronal connectivity, such as dendritic morphology, axonal targeting or synaptic specificity, ultimately priming the neuron for incorporation into emerging circuitry. As the neuron's early connectivity is established, extrinsic signals from its pre- and postsynaptic partners feedback on the neuron to further refine its unique characteristics. As a result, disruption of one component of the circuitry during development can have vital consequences for the proper identity specification of its synaptic partners. Recent studies have begun to harness the power of various transcription factors that control neuronal cell fate, including those that specify a neuron's subtype-specific identity, seeking insight for future therapeutic strategies that aim to reconstitute damaged circuitry through neuronal reprogramming.Entities:
Keywords: Fezf2; Ptf1a; circuit formation; neuronal identity; subtype-specification; transcription factors
Mesh:
Substances:
Year: 2014 PMID: 25297387 PMCID: PMC4221895 DOI: 10.1098/rsob.140144
Source DB: PubMed Journal: Open Biol ISSN: 2046-2441 Impact factor: 6.411
Figure 1.Fezf2 and Ptf1a are necessary and sufficient for a subtype-specific identity. Column 1 illustrates the role of Fezf2 in controlling CFuPN identity. In Fezf2 mice (row 1), CFuPNs primarily acquire a CPN identity, which causes these cells to project axons across the corpus callosum rather than to subcortical targets [10,32]. Misexpression of Fezf2 (+Fezf2) in CPNs or layer IV pyramidal cells in the cortex (rows 2 and 3), or in striatal medium spiny neurons (MSNs) (row 4), is sufficient to convert their identity to resemble that of CFuPNs, which includes changes in their molecular profile, neuronal morphology, and projection of axons to subcortical targets [11,12,33,34]. In the case of MSNs, this also includes a change in neurotransmitter status from inhibitory to excitatory [34]. Column 2 illustrates the role of Ptf1a in controlling an inhibitory neuronal identity in various regions of the CNS. Ptf1a is necessary for specifying the identity of dI4 interneurons in the spinal cord, inhibitory interneurons and Purkinje cells in the cerebellum, and amacrine and horizontal cells in the retina (rows 1–3). Without Ptf1a expression (Ptf1a), these neurons adopt the features of their excitatory counterparts: dI5 cells in the spinal cord, granule cells in the cerebellum and retinal ganglion cells (RGCs) in the retina [13–17]. Misexpression of Ptf1a (+Ptf1a) in the developing spinal cord (row 4), cerebellum (row 5) or retina (row 6) is sufficient to promote an inhibitory interneuronal identity, causing dI5 cells to differentiate with dI4 properties in the spinal cord, granule cells to differentiate with inhibitory interneuron or Purkinje cell properties in the cerebellum, and RGCs to differentiate with amacrine and horizontal cell properties in the retina [35–40]. Misexpression of Ptf1a in cortical pyramidal cells (row 7) is sufficient to induce features of an inhibitory peptidergic identity, including an alteration in cellular morphology and neurotransmitter status [19]. ‘+’ indicates an excitatory neurotransmitter status, ‘−’ indicates an inhibitory neurotransmitter status.
Figure 2.Misexpression of Fezf2 in striatal MSNs or of Ptf1a in cortical pyramidal cells cell-autonomously promotes subtype-specific features. Misexpression studies of Fezf2 in the striatum and Ptf1a in the cortex, regions of the CNS where these transcription factors are not endogenously expressed, demonstrate their sufficiency to cell-autonomously promote features of a CFuPN or inhibitory peptidergic interneuron, respectively. Column 1 illustrates how misexpression of Fezf2 (+Fezf2) induces MSN identity to resemble that of CFuPNs. From top to bottom, this involves alterations in the MSN molecular profile, a change in cellular morphology from a stellate to a pyramidal morphology, the induction of axonal targeting toward subcortical targets, such as the spinal cord, and a shift toward a glutamatergic neurotransmitter status [34]. Column 2 illustrates how misexpression of Ptf1a (+Ptf1a) induces pyramidal cell identity to resemble that of inhibitory peptidergic interneurons. From top to bottom, this involves alterations in the pyramidal cell molecular profile, a change in cellular morphology from a pyramidal to a more radial, branched morphology, adoption of a tangential migration pattern and the induction of a primarily nociceptinergic neurotransmitter status [15,19]. Plus sign ‘+’ indicates an excitatory neurotransmitter status, minus sign ‘−’ indicates an inhibitory neurotransmitter status. glu, glutamate; noc, nociceptin.